American Journal of Clinical Dermatology

Article	Citations
The Current State of Systemic Therapy of Metastatic Uveal Melanoma	153
Alcohol and Smoking Cessation as Potential Modulators for Smoking-Associated Psoriasis Risk in Postmenopausal Women: The Women’s Health Initiative	143
Prognostic Biomarkers in Evolving Melanoma Immunotherapy	139
Role of Inflammation and Cytokine Dysregulation in Depression in Patients with Inflammatory Skin Conditions	128
New Onset and Exacerbations of Psoriasis Following COVID-19 Vaccines: A Systematic Review	97
Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments	94
Economic Burden of Chronic Hand Eczema: A Review	94
Deciphering the Etiologies of Adult Erythroderma: An Updated Guide to Presentations, Diagnostic Tools, Pathophysiologies, and Treatments	86
Predicting the Time to Relapse Following Withdrawal from Different Biologics in Patients with Psoriasis who Responded to Therapy: A 12-Year Multicenter Cohort Study	84
Stepping Down Treatment in Chronic Spontaneous Urticaria: What We Know and What We Don’t Know	79
Obesity in Hidradenitis Suppurativa: Are GLP-1 Receptor Agonists the New Frontier?	71
Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology	70
Agreement Between Nail Psoriasis Severity Index Scores by a Convolutional Neural Network and Dermatologists: A Retrospective Study at an Academic New York City Institution	67
Primary Localized Cutaneous Amyloidosis of Keratinocyte Origin: An Update with Emphasis on Atypical Clinical Variants	66
Efficacy and Safety of Nail Psoriasis Targeted Therapies: A Systematic Review	63
Chlormethine Gel Versus Chlormethine Ointment for Treatment of Patients with Mycosis Fungoides: A Post-Hoc Analysis of Clinical Trial Data	54
A Practical Approach to the Diagnosis and Management of Classic Lichen Planopilaris	54
Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroi	49
Behçet Disease: An Update for Dermatologists	49
Comment on: “Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?”	48
Pathophysiology of Generalized Pustular Psoriasis	48
Correction to: Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion	47
Inpatient Teledermatology Improves Diagnostic Accuracy and Management of Leg Ulcers in Hospitalized Patients	45
Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment	45
Disease Modification in Psoriasis: Future Prospects for Long-Term Remission	45

Skin Cancer in People of Color: A Systematic Review	44
Drug Survival of Oral Retinoids in Hidradenitis Suppurativa: A Real-Life Cohort Study	44
Lessons Learned from Orthopedics: A Call to Action for More Rigorous Platelet-Rich Plasma Hair Loss Clinical Trials	42
Candida Infection Associated with Anti-IL-17 Medication: A Systematic Analysis and Review of the Literature	42
Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation	41
Truncal Acne and Scarring: A Comprehensive Review of Current Medical and Cosmetic Approaches to Treatment and Patient Management	41
Real-World Evidence on Dose Spacing of IL-23 Inhibitors in the Treatment of Psoriasis	39
Biomarkers in Atopic Dermatitis: A Review of the Role of IL-13 and the Impact of Tralokinumab Treatment	39
Atopic Dermatitis: Fertility, Pregnancy, and Treatment Perspectives	39
Real-World Evidence of Tralokinumab Effectiveness and Safety: A Systematic Review and Meta-analysis	37
Management and Long-Term Outcomes of Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS) in Children: A Scoping Review	37
A Practice Approach to Acne Fulminans in Adolescents	37
Correction to: AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment Hist	37
Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic Updates	36
A Review of the Etiologies and Key Clinical Features of Secondary Hyperhidrosis	36
Long-Term Safety and Tolerability of Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa	36
Multiple Keratoacanthomas Associated with Genetic Syndromes: Narrative Review and Proposal of a Diagnostic Algorithm	33
Oral Lichen Planus: An Update on Diagnosis and Management	33
Scratching the Surface: A Comprehensive Guide to Understanding and Managing Vulvovaginal Itching	33
Patient and Public Involvement in Dermatology Research: A Review	33
The Use of Biologic Agents for the Treatment of Cutaneous Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Review of Reported Cases	32
Appraisal of Proactive Topical Therapy in Atopic Dermatitis: Pros and Cons	31
Individualized Neoantigen-Directed Melanoma Therapy	30
Granuloma Annulare: An Updated Review of Epidemiology, Pathogenesis, and Treatment Options	30
Frontal Fibrosing Alopecia: An Update	30
Commentary on “Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology”	30
Targeting Inflammation in Acne: Current Treatments and Future Prospects	29
Differential Diagnosis, Prevention, and Treatment of mpox (Monkeypox): A Review for Dermatologists	29
Tree-Based Machine Learning to Identify Predictors of Psoriasis Incidence at the Neighborhood Level: A Populational Study from Quebec, Canada	29
JAK Inhibitors and Inflammatory Nail Disorders: A Systematic Review of Clinical Outcomes and Therapeutic Potential	28
AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History	28
Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials	28
Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: a 2-Year Real-Life Multicenter Study	27
Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)	26
Autoimmune and Cutaneous Inflammatory Comorbidities in Adult-Onset Morphea in the All of Us Research Program	26
Cutaneous Small Vessel Vasculitis: A Practical Guide to Diagnosis and Management	25
Approach to the Atypical Wound	25
Comment on: “Eyebrow and Eyelash Alopecia: A Clinical Review”	24
Beyond the Herald Patch: Exploring the Complex Landscape of Pityriasis Rosea	23
Dupilumab Facial Redness/Dupilumab Facial Dermatitis: A Guide for Clinicians	23
Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study	23
Intravenous Immunoglobulin Therapy for Pyoderma Gangrenosum: A Multicenter Retrospective Analysis in 81 Patients	23
Acknowledgement to Referees	23
Systemic Versus Topical Corticosteroids in the Treatment of DRESS: A Retrospective Cohort Study Followed by a Meta-Analysis	22
Investigational Treatments for Epidermolysis Bullosa	22
Management of Acne in Pregnancy	22
Burden to Partners of People with Psoriasis: Results from the FamilyPso International Study	22
Impact of Generalized Pustular Psoriasis from the Perspective of People Living with the Condition: Results of an Online Survey	21
Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion	21
Real-World Use of Ruxolitinib Cream: Safety Analysis at 1 Year	21

Treatment Strategies for Chronic Pruritus and Eczema/Dermatitis in Older Adults Under the Category of Chronic Eczematous Eruptions of Aging (CEEA)	21
Identifying and Treating Ocular Manifestations in Psoriasis	21
An Update on New and Existing Treatments for the Management of Melasma	20
Comprehensive and Updated Algorithm of Hidradenitis Suppurativa Management from the Experts	20
Safety of Hydroxychloroquine: What a Dermatologist Should Know	20
Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials	20
The 25th World Congress of Dermatology, Singapore, 3–8 July, 2023: Research Highlights	20
Review of Perineural Invasion in Keratinocyte Carcinomas	20
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study	19
Disease Burden and Treatment Patterns Among US Patients with Hidradenitis Suppurativa: A Retrospective Cohort Study	19
Review of Laser Treatments for Post-Inflammatory Hyperpigmentation in Skin of Color	19
Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2	19
Autoimmune, Autoinflammatory Disease and Cutaneous Malignancy Associations with Hidradenitis Suppurativa: A Cross-Sectional Study	18
Ceramides in Skin Health and Disease: An Update	18
Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”	18
Melanoma Brain Metastases: An Update on the Use of Immune Checkpoint Inhibitors and Molecularly Targeted Agents	18
Patient Care Outcomes in Hospitalized Patients with Acute Generalized Exanthematous Pustulosis: A Cross-Sectional Database Study	17
Diagnosis and Management of Dermatologic Adverse Events from Systemic Melanoma Therapies	17
Update in Diagnosis and Management of Primary Cutaneous B-Cell Lymphomas	17
Correction to: Authors’ Reply to Chen and Chen: Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”	17
Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies	17
Psychosocial Effects of Vitiligo: A Systematic Literature Review	16
Review of an Anti-CD20 Monoclonal Antibody for the Treatment of Autoimmune Diseases of the Skin	16
Real-World Effectiveness, Safety, and Drug Survival of Risankizumab in Adult Patients with Plaque Psoriasis: A 3-Year Multicenter Retrospective Cohort Study	16
Abscopal Effects and Immunomodulation in Skin Cancer Therapy	16
Treatment of Hyperhidrosis: An Update	16
Atopic Dermatitis Across Shades of Skin	15
Real-World Experience of Bimekizumab for Plaque Psoriasis in Adult Patients with Prior Exposure to Interleukin-23 Inhibitors: A Multicenter Retrospective Study	15
The Skin and Gut Microbiome in Hidradenitis Suppurativa: Current Understanding and Future Considerations for Research and Treatment	15
Phase II, Double-Blind, Vehicle-Controlled Study to Determine the Cantharidin Dose Regimen, Efficacy, Safety, and Tolerability of VP-102 in Subjects with External Genital Warts	15
Pharmacokinetics of Roflumilast Cream in Chronic Plaque Psoriasis: Data from Phase I to Phase III Studies	15
KECORT Study: An International e-Delphi Study on the Treatment of KEloids Using Intralesional CORTicosteroids in Clinical Practice	15
Clinical Effectiveness and Safety of Initial Combination Therapy with Corticosteroids and Rituximab in Bullous Pemphigoid: A Retrospective Cohort Study	15
Management of Coexisting Bullous Pemphigoid and Psoriasis: A Review	14
Automated Facial Acne Lesion Detecting and Counting Algorithm for Acne Severity Evaluation and Its Utility in Assisting Dermatologists	14
Impact of Facial Atrophic Acne Scars on Quality of Life: A Multi-country Population-Based Survey	13
Oral Roflumilast in Patients with Psoriasis: A Real-World Cohort Study	13
New Practical Aspects of Sweet Syndrome	13
Lichen Planus: What is New in Diagnosis and Treatment?	13
Blue Nail Discoloration: Literature Review and Diagnostic Algorithms	13
Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials	13
Human Inborn Errors of Immunity in Pyoderma Gangrenosum: A Systematic Review	13
Authors’ reply to Borg and Thoning: “Comment on: Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study”	13
Diagnosis of Generalized Pustular Psoriasis	12
Cutaneous Manifestations of Inflammatory Bowel Disease: A Basic Overview	12
Correction to: The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma	12
Ruxolitinib Cream 1.5%: A Review in Mild to Moderate Atopic Dermatitis	12
Meat Allergy: A Ticking Time Bomb	12
Suggestions for a New Clinical Classification Approach to Panniculitis Based on a Mayo Clinic Experience of 207 Cases	12
Efinaconazole in Onychomycosis	12
Dapsone Use in Dermatology	12
Cholestatic Itch: Our Current Understanding of Pathophysiology and Treatments	11
Recommendations for Vaccination in Children with Atopic Dermatitis Treated with Dupilumab: A Consensus Meeting, 2020	11
Ultrasound Surveillance in Melanoma Management: Bridging Diagnostic Promise with Real-World Adherence: A Systematic Review and Meta-Analysis	11
Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial	11
Cellulitis in Pediatric Patients: Recognition and Management in the Era of Evolving Resistance	11
Correction to: Adherence to Hidradenitis Suppurativa Treatment	11
Adherence to Hidradenitis Suppurativa Treatment	10
Alopecia Areata: Current Treatments and New Directions	10
Eyebrow and Eyelash Alopecia: A Clinical Review	10
Features and Long-Term Outcomes of Stage IV Melanoma Patients Achieving Complete Response Under Anti-PD-1-Based Immunotherapy	10
Vulvar Melanoma: Molecular Characteristics, Diagnosis, Surgical Management, and Medical Treatment	10
Correction to: Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program	10
Correction to: Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient	10
What’s New in Therapy for Male Androgenetic Alopecia?	10
Chronic Prurigo Including Prurigo Nodularis: New Insights and Treatments	10
Comment on: “Methotrexate Cutaneous Ulceration: A Systematic Review of Cases”	9
Correction to: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program	9
Beyond the Hot Comb: Updates in Epidemiology, Pathogenesis, and Treatment of Central Centrifugal Cicatricial Alopecia from 2011 to 2021	9
Deucravacitinib for the Treatment of Psoriatic Disease	9
The Role of Diet Modification in Atopic Dermatitis: Navigating the Complexity	9
A Guide to the Management of Hidradenitis Suppurativa in Pregnancy and Lactation	9
Field Cancerization Therapies for the Management of Actinic Keratosis: An Updated Review	9
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Cl	8
Psychological Therapies and Mind–Body Techniques in the Management of Dermatologic Diseases: A Systematic Review	8
Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials	8
Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis	8
Relationship of Histopathologic Parameters and Gene Expression Profiling in Malignant Melanoma	8
Skin Toxicities with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Signals from Disproportionality Analysis of the FDA Adverse Event Reporting System	8
Pruritus in Pregnancy	8

Publisher Correction to: Multiple Keratoacanthomas Associated with Genetic Syndromes: Narrative Review and Proposal of a Diagnostic Algorithm	8
American Academy of Dermatology Annual Meeting: San Diego, CA, USA, 8–12 March 2024	7
Stasis Dermatitis: An Overview of Its Clinical Presentation, Pathogenesis, and Management	7
Association of Cardiovascular Disease and Chronic Spontaneous Urticaria: A Case–Control Study	7
Maximal Usage Trial of Tapinarof Cream 1% Once Daily in Pediatric Patients Down to 2 Years of Age with Extensive Atopic Dermatitis	7
Clinical Efficacy and Safety of Interleukin-17 Inhibitors in Treating Patients with Erythrodermic Psoriasis: A Retrospective Cohort, Three-Center Study	7
Evaluating the Longitudinal Course of Atopic Dermatitis: Implications for Clinical Practice	7
Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for ≥ 156 Consecutive Weeks: A Post-Hoc Analysis From the VOYAGE 1 Clinical Trial	7
Expert Perspectives on Key Parameters that Impact Interpretation of Randomized Clinical Trials in Moderate-to-Severe Atopic Dermatitis	7
Development of Cutaneous T-Cell Lymphoma Following Biologic Treatment: A Systematic Review	7
Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial	7
Acknowledgment to Referees	6
Lactobacillus rhamnosus Used in the Perinatal Period for the Prevention of Atopic Dermatitis in Infants: A Systematic Review and Meta-Analysis of Randomized Trials	6
Sequencing of Targeted Therapy in Psoriasis: Does it Matter?	6
Determinants and Effectiveness of BNT162b2 mRNA Vaccination Among Patients with Atopic Dermatitis: A Population-Based Study	6
Efficacy and Safety of Brodalumab, an Anti-interleukin-17 Receptor A Monoclonal Antibody, for Palmoplantar Pustulosis: 16-Week Results of a Randomized Clinical Trial	6
Global Incidence, Mortality, Risk Factors and Trends of Melanoma: A Systematic Analysis of Registries	6
Rare Autoinflammatory Neutrophilic Dermatoses in Pregnancy: Literature Review	6
Hidradenitis Suppurativa: New Targets and Emerging Treatments	6
Characterization of Clinicopathological Features and Autoantibody Profiles in Patients with Cutaneous Lupus Erythematous: A Single-Center Retrospective Study	6